Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
Condition(s):Acute Lymphoblastic Leukemia; B Cell LymphomaLast Updated:August 7, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Lymphoblastic Leukemia; B Cell LymphomaLast Updated:August 7, 2019Unknown status
Condition(s):Acute Lymphoblastic Leukemia; B Cell LymphomaLast Updated:May 10, 2019Unknown status
Condition(s):Acute Lymphoblastic Leukemia; B Cell LymphomaLast Updated:November 20, 2018Unknown status
Condition(s):Acute Lymphoblastic Leukemia; B Cell LymphomaLast Updated:May 10, 2019Unknown status
Condition(s):Diffuse Large B Cell Lymphoma; Burkitt Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell LymphomaLast Updated:July 25, 2023Recruiting
Condition(s):CS1+ or BCMA+ Multiple MyelomaLast Updated:August 16, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.